Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 4—April 2011

Bordetella petrii Infection with Long-lasting Persistence in Human

Alain Le Coustumier, Elisabeth Njamkepo, Vincent Cattoir, Sophie Guillot, and Nicole GuisoComments to Author 
Author affiliations: Author affiliations: Centre Hospitalier, Cahors, France (A. Le Coustumier); Institut Pasteur, Paris, France (E. Njamkepo, S. Guillot, N. Guiso); Centre Hospitalier Universitaire, Côte de Nacre, Caen, France (V. Cattoir)

Main Article

Table 2

Antimicrobial drug susceptibility testing for Bordetella petrii isolates, by strain and strain type, October 2007–November 2008*

Drug FR 3799, clinical† FR3891, clinical† FR 3996, clinical† FR 3497, clinical (17) KMRW, environmental (1) Fry et al., clinical (16)‡ Stark et al., clinical (18)
Penicillin >32 >32 >32 >32 >32 >32 ND
Amoxicillin >256 >256 >256 >256 8 >256 +clav: 4
Piperacillin 16 12 12 256 0.25 ND ND
Piperacillin and tazobactam 16 48 24 256 0.38 2 <4
Cefotaxime >32 >32 >32 >32 >32 >32 Ceftriax: >64
Ceftazidime 48 256 >256 2 4 32 16
Ertapenem >32 >32 >32 0.016 0.047 >32 ND
Imipenem 3 4 8 1 0.75 >32 ND
Meropenem 12 >32 12 0.023 0.047 >32 <0.25
Doripenem 32 >32 >32 0.094 0.125 ND ND
Gentamicin 1 1 1.5 12 3 4 4
Tobramycin 1 1 1 64 4 16 2
Amikacin 8 16 16 64 48 >256 8
Levofloxacin 16 24 24 2 0.25 ND ND
Ciprofloxacin >32 >32 >32 4 0.38 >32 2
Moxifloxacin 12 12 12 1.5 0.032 ND ND
Minocyclin 0.75 0.75 0.75 0.5 0.125 ND ND
Tygecyclin 0.75 1 1 0.25 0.023 ND ND
Cotrimoxazole 0.50 0.50 0.50 0.012 0.006 8 ND
Fosfomycin 4 8 8 6 12 ND ND
Quinupristin and dalfopristin >32 >32 >32 >32 >32 ND ND
Rifampin >32 >32 >32 >32 >32 >32 ND
Daptomycin >256 >256 >256 >256 >256 ND ND
Linezolid >256 >256 >256 >256 >256 ND ND
Clindamycin >256 >256 >256 >256 >256 >256 ND
Fucidic acid >256 >256 >256 >256 >256 ND ND

*Values are MICs by Etest in μg/mL. +clav, in combination with clavulanic acid; Ceftriax, ceftriaxone tested instead of cefotaxime; ND, not determined.
†This study.
‡Ampicillin was tested instead of amoxicillin.

Main Article

  1. von Wintzingerode  F, Schattke  A, Siddiqui  RA, Rosick  U, Göbel  UB, Gross  R. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol. 2001;51:125765.PubMed
  2. Ko  KS, Peck  KR, Oh  WS, Lee  NY, Lee  JH, Song  JH. New species of Bordetella, Bordetella ansorpii sp. nov., isolated from the purulent exudate of an epidermal cyst. J Clin Microbiol. 2005;43:25169. DOIPubMed
  3. Fry  NK, Duncan  J, Malnick  H, Cockcroft  PM. The first UK isolate of ‘Bordetella ansorpii’ from an immunocompromised patient. J Med Microbiol. 2007;56:9935. DOIPubMed
  4. Vandamme  P, Heyndricks  M, Vancanneyt  M, Hoste  B, De Vos  P, Falsen  E, Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of alcaligenes denitrificans rüger and tan 1983. Int J Syst Bacteriol. 1996;46:84958. DOIPubMed
  5. Mattoo  S, Cherry  JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:32682. DOIPubMed
  6. Cookson  BT, Vandamme  P, Carlson  LC, Larson  AM, Sheffield  JV, Kersters  K, Bacteremia caused by a novel Bordetella species, “B. hinzii. J Clin Microbiol. 1994;32:256971.PubMed
  7. Funke  G, Hess  T, von Graevenitz  A, Vandamme  P. Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol. 1996;34:9669.PubMed
  8. Harrington  AT, Castellanos  JA, Ziedalski  TM, Clarridge  JE III, Cookson  BT. Isolation of Bordetella avium and novel Bordetella strain from patients with respiratory disease. Emerg Infect Dis. 2009;15:724. DOIPubMed
  9. Vandamme  P, Hommez  J, Vancanneyt  M, Monsieurs  M, Hoste  B, Cookson  B, Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol. 1995;45:3745. DOIPubMed
  10. Gross  R, Keidel  K, Schmitt  K. Resemblance and divergence: the “new” members of the genus Bordetella. Med Microbiol Immunol (Berl). 2010;199:15563. DOIPubMed
  11. Goodnow  RA. Biology of Bordetella bronchiseptica. Microbiol Rev. 1980;44:72238.PubMed
  12. Gueirard  P, Weber  C, Le Coustumier  A, Guiso  N. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol. 1995;33:20026.PubMed
  13. Yih  WK, Silva  EA, Ida  J, Harrington  N, Lett  SM, George  H. Bordetella holmesii–like organisms isolated from Massachussetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999;5:4413. DOIPubMed
  14. Weyant  RS, Hollis  DG, Weaver  RE, Amin  MFM, Steigerwalt  AG, O'Connor  SP, Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol. 1995;33:17.PubMed
  15. Tang  YW, Hopkins  MK, Kolbert  CP, Hartley  PA, Severance  PJ, Persing  DH. Bordetella holmesii–like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis. 1998;26:38992. DOIPubMed
  16. Fry  NK, Duncan  J, Malnick  H, Warner  M, Smith  AJ, Jackson  MS, Bordetella petrii clinical isolate. Emerg Infect Dis. 2005;11:11313.PubMed
  17. Moissenet  D, Bingen  E, Arlet  G, Vu-Thien  H. Use of 16s rRNA gene sequencing for identification of “Pseudomonas-like” isolates from sputum of patients with cystic fibrosis. Pathol Biol (Paris). 2005;53:5002. DOIPubMed
  18. Stark  D, Riley  LA, Harkness  J, Marriott  D. Bordetella petrii from a clinical sample in Australia: isolation and molecular identification. J Med Microbiol. 2007;56:4357. DOIPubMed
  19. Spilker  T, Liwienski  AA. LiPuma JJ. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect. 2008;14:5046. DOIPubMed
  20. Diavatopoulos  DA, Cummings  CA, van der Heide  HG, van Gent  M, Liew  S, Relman  DA, Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol. 2006;188:838594. DOIPubMed
  21. Buboltz  AM, Nicholson  TL, Parette  MR, Hester  SE, Parkhill  J, Harvill  ET. Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol. 2008;190:550211. DOIPubMed
  22. Gross  R, Guzman  CA, Sebaihia  M, dos Santos  VA, Pieper  DH, Koebnik  R, The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic bordetellae. BMC Genomics. 2008;9:449. DOIPubMed
  23. Lechner  M, Schmitt  K, Bauer  S, Hot  D, Hubans  C, Levillain  E, Genomic island excisions in Bordetella petrii. BMC Microbiol. 2009;9:141. DOIPubMed
  24. Bartlett  JG, Brewer  NS, Ryan  KJ. Cumitech 7, laboratory diagnosis of lower respiratory tract infections. In: Washington JA II, editor. Respiratory tract infections. Washington: American Society for Microbiology; 1978.
  25. Référentiel en Microbiologie Médicale (RÉMIC). Diagnostic microbiologique des infections broncho-pulmonaires. In: RÉMIC vol 13. Paris: Société Française Microbiologie; 2010. p. 93–8.
  26. Heininger  U, Cotter  PA, Fescemyer  HW, Martinez De Tejada  G, Yuk  MH, Miller  JF, Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun. 2002;70:377784. DOIPubMed
  27. Parkhill  J, Sebaihia  M, Preston  A, Murphy  LD, Thomson  N, Harris  DE, Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet. 2003;35:3240. DOIPubMed
  28. Njamkepo  E, Delisle  F, Hagege  I, Gerbaud  G, Guiso  N. Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect. 2000;6:1316. DOIPubMed
  29. Edwards  U, Rogall  T, Blocker  H, Emde  M, Bottger  EC. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res. 1989;17:784353. DOIPubMed
  30. Janvier  M, Grimont  PA. The genus Methylophaga, a new line of descent within phylogenetic branch gamma of proteobacteria. Res Microbiol. 1995;146:54350. DOIPubMed
  31. Thompson  JD, Higgins  DG, Gibson  TJ. Clustal w: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:467380. DOIPubMed
  32. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing—twentieth informational supplement: approved standard m100-s120. Wayne (PA): The Institute; 2010.
  33. Comité de l'Antibiogramme de la Société Française de Microbiologie  C. 2010 [cited 2011 Feb 15].
  34. Caro  V, Njamkepo  E, Van Amersfoorth  SC, Mooi  FR, Advani  A, Hallander  HO, Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various european countries with different vaccine policies. Microbes Infect. 2005;7:97682. DOIPubMed
  35. Khelef  N, Danve  B, Quentin-Millet  MJ, Guiso  N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun. 1993;61:48690.PubMed
  36. Bassinet  L, Gueirard  P, Maitre  B, Housset  B, Gounon  P, Guiso  N. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun. 2000;68:193441. DOIPubMed
  37. Zbinden  A, Böttger  EC, Bosshard  PP, Zbinden  R. Evaluation of the colorimetric VITEC 2 card for identification of gram-negative nonfermentative rods: comparison to 16S rRNA gene sequencing. J Clin Microbiol. 2007;45:22703. DOIPubMed
  38. Hill  BC, Baker  CN, Tenover  FC. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol. 2000;38:11515.PubMed

Main Article

Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.